Literature DB >> 32203253

Clinical and genetic variability of PAX2-related disorder in the Japanese population.

Rini Rossanti1, Naoya Morisada2,3, Kandai Nozu1, Koichi Kamei4, Tomoko Horinouchi1, Tomohiko Yamamura1, Shogo Minamikawa1,5, Junya Fujimura1,6, China Nagano1, Nana Sakakibara1, Takeshi Ninchoji1, Hiroshi Kaito1,7, Shuichi Ito4,8, Ryojiro Tanaka5,7, Kazumoto Iijima1.   

Abstract

Pathogenic variants of paired box gene 2 (PAX2) cause autosomal-dominant PAX2-related disorder, which includes renal coloboma syndrome (RCS). Patients with PAX2-related disorder present with renal and ophthalmological pathologies, as well as with other abnormalities, including developmental problems and hearing loss. We sequenced PAX2 in 457 patients with congenital anomalies of the kidney and urinary tract or with renal dysfunction of unknown cause and identified 19 different pathogenic variants in 38 patients from 30 families (6.5%). Thirty-four patients had renal hypodysplasia or chronic kidney disease of unknown cause, and three had focal segmental glomerulosclerosis. Although no obvious genotype-phenotype correlation was observed, six of the seven patients who developed end-stage renal disease in childhood had truncating variants. Twenty-three patients had ocular disabilities, mostly optic disc coloboma. Non-renal and non-ophthalmological manifestations included developmental disorder, electrolyte abnormality, and gonadal abnormalities. Two unrelated patients had congenital cystic adenomatoid malformations in their lungs. Six of ten probands with PAX2 mutation identified by next-generation sequencing did not show typical RCS manifestations. We conclude that PAX2-related disorder has a variable clinical presentation and can be diagnosed by next-generation sequencing even in the absence of typical RCS manifestations.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32203253     DOI: 10.1038/s10038-020-0741-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

Review 1.  Pathomechanisms of Congenital Cystic Lung Diseases: Focus on Congenital Cystic Adenomatoid Malformation and Pleuropulmonary Blastoma.

Authors:  Olivier Boucherat; Lucie Jeannotte; Alice Hadchouel; Christophe Delacourt; Alexandra Benachi
Journal:  Paediatr Respir Rev       Date:  2016-02-03       Impact factor: 2.726

2.  PAX2 gene mutation in a family with isolated renal hypoplasia.

Authors:  Kaori Nishimoto; Kazumoto Iijima; Taku Shirakawa; Kousaku Kitagawa; Kenichi Satomura; Hajime Nakamura; Norishige Yoshikawa
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

3.  Spatially and temporally restricted expression of Pax2 during murine neurogenesis.

Authors:  H O Nornes; G R Dressler; E W Knapik; U Deutsch; P Gruss
Journal:  Development       Date:  1990-08       Impact factor: 6.868

4.  Pax-2 controls multiple steps of urogenital development.

Authors:  M Torres; E Gómez-Pardo; G R Dressler; P Gruss
Journal:  Development       Date:  1995-12       Impact factor: 6.868

  4 in total
  8 in total

Review 1.  The genetic basis of congenital anomalies of the kidney and urinary tract.

Authors:  Maayan Kagan; Oren Pleniceanu; Asaf Vivante
Journal:  Pediatr Nephrol       Date:  2022-02-04       Impact factor: 3.651

2.  A novel PAX2 heterozygous mutation in a family with Papillorenal syndrome: A case report and review of the literature.

Authors:  Shixue Liu; Peijun Zhang; Jihong Wu; Qing Chang
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-22

3.  Detection of De Novo PAX2 Variants and Phenotypes in Chinese Population: A Single-Center Study.

Authors:  Hua-Ying Xiong; Yong-Qi Shi; Cheng Zhong; Qin Yang; Gaofu Zhang; Haiping Yang; Daoqi Wu; Yaxi Chen; Qiu Li; Mo Wang
Journal:  Front Genet       Date:  2022-03-31       Impact factor: 4.772

4.  Deciphering the mutation spectrum in south Indian children with congenital anomalies of the kidney and urinary tract.

Authors:  Ambili Narikot; Varsha Chhotusing Pardeshi; A M Shubha; Arpana Iyengar; Anil Vasudevan
Journal:  BMC Nephrol       Date:  2022-01-03       Impact factor: 2.388

5.  PAX2 Mutation-Related Renal Hypodysplasia: Review of the Literature and Three Case Reports.

Authors:  Yu-Ming Chang; Chih-Chia Chen; Ni-Chung Lee; Junne-Ming Sung; Yen-Yin Chou; Yuan-Yow Chiou
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

Review 6.  The Role of PAX2 in Neurodevelopment and Disease.

Authors:  Na Lv; Ying Wang; Min Zhao; Lina Dong; Hongen Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-07       Impact factor: 2.570

7.  Phenotypic spectrum and genetics of PAX2-related disorder in the Chinese cohort.

Authors:  Xue Yang; Yaqi Li; Ye Fang; Hua Shi; Tianchao Xiang; Jiaojiao Liu; Jialu Liu; Xiaoshan Tang; Xiaoyan Fang; Jing Chen; Yihui Zhai; Qian Shen; Yunli Bi; Yanyan Qian; Bingbing Wu; Huijun Wang; Wenhao Zhou; Duan Ma; Haitao Bai; Jianhua Mao; Lizhi Chen; Xiaowen Wang; Xiaojie Gao; Ruifeng Zhang; Jieqiu Zhuang; Aihua Zhang; Xiaoyun Jiang; Hong Xu; Jia Rao
Journal:  BMC Med Genomics       Date:  2021-10-25       Impact factor: 3.063

8.  Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Silvia Reichart; Charlotte Philpott; Kate E Lines; Caroline M Gorvin; Karl Lhotta; Jenny C Taylor; Rajesh V Thakker
Journal:  Am J Med Genet A       Date:  2020-08-09       Impact factor: 2.578

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.